Evolution of Guidelines on Peanut Allergy and Peanut Introduction in Infants: A Review

Sara Anvari1, Niti Y Chokshi2, Qurat Ul Ain Kamili3

  • 1Division of Immunology, Allergy and Rheumatology, Texas Children's Hospital, Houston2Baylor College of Medicine, Houston, Texas.

JAMA Pediatrics
|November 8, 2016
PubMed

Insights

Early introduction of peanut products in infancy is recommended to prevent peanut allergies. Emerging evidence shows that introducing allergenic foods early, rather than delaying, offers significant benefits for children's health.

Area of Science:

  • Pediatric Allergy and Immunology
  • Public Health

Background:

  • Peanut allergy prevalence in US children has tripled in two decades.
  • Previous guidelines (2000) recommended delayed peanut introduction.
  • Recent evidence contradicts delayed introduction strategies.

Purpose of the Study:

  • To review the evolution of medical guidelines regarding peanut introduction in infants.
  • To highlight studies influencing current recommendations on early allergen exposure.

Main Methods:

  • Literature review of studies on peanut allergy and infant feeding guidelines.
  • Analysis of the impact of emerging evidence on pediatric allergy recommendations.

Main Results:

  • Guidelines have shifted from delayed to early introduction of peanut products.
  • Studies demonstrate that early introduction is more beneficial for preventing peanut allergy.
  • Current evidence supports timely introduction during infancy.

Conclusions:

  • Evolving guidelines now favor early peanut introduction for infants.
  • Early exposure is a key strategy in preventing the development of peanut allergies.
  • This shift reflects a significant change in pediatric allergy management.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
669
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Allergic Reactions02:06

Allergic Reactions

Overview
33.2K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
110
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349